The FDA has approved EchoPixel’s True3D Viewer which converts anatomical data to 3D virtual reality images.
The FDA has approved EchoPixel’s True3D Viewer, the first platform to convert anatomical data from patients into fully interactive, 3D virtual reality images, EchoPixel announced yesterday.
True3D compiles data from MRI, CT, and all DICOM imaging data to create an interactive holograph of patient-specific body parts, instead of flat 2D images, EchoPixel said in a release. The rendering allows physicians and students to interact with the anatomical structures. True3D’s technology is an effort to dramatically improve speed and efficacy across a broad range of medical operations, the release said.
“Since CT scans were invented in the 1970s, doctors have learned about patient anatomy by mentally piecing together multiple images on flat screens,” Ron Schilling, CEO of EchoPixel, said in the release. “That’s not what the inside of a patient looks like. When working with doctors, we found they were wasting energy trying to solve imaging problems instead of clinical ones. Using virtual reality, we can provide an interactive, three-dimensional view of patient data that is far clearer and more realistic.”
Early clinical trials have shown True3D technology to impact procedures in surgery and radiology, the release said. EchoPixel uses proprietary protocols to formulate and distribute expert-derived methodologies in step-by-step 3D format, according to the release.
[[{"type":"media","view_mode":"media_crop","fid":"33441","attributes":{"alt":"t3D Viewer","class":"media-image","id":"media_crop_6027850334752","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3525","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 209px; width: 400px;","title":"t3D Viewer","typeof":"foaf:Image"}}]]
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 4th 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 4th 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 4th 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 4th 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
August 4th 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.